Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12230753 | 0.81 | LMNA (0.43) | CTSLCTSBCTSK | |
| SCHEMBL10299282 | 0.77 | MMP1 (0.32) | CTSLCTSBCTSK | |
| SCHEMBL19821996 | 0.76 | CTSL (0.37) | CTSLCTSBCTSK | |
| SCHEMBL9065292 | 0.75 | MGAM (0.38) | — | |
| SCHEMBL11601735 | 0.75 | LMNA (0.41) | — | |
| SCHEMBL1171171 | 0.73 | — | — | |
| SCHEMBL7233887 | 0.73 | — | — | |
| SCHEMBL16904007 | 0.71 | — | — | |
| SCHEMBL10875233 | 0.71 | MMP1 (0.54) | — | |
| SCHEMBL27299233 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841281-B2 | Transition metal complexes of amino acids and related ligands and their use as catalysts, anti-microbials, and anti-cancer agents | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2014-09-23 | — | — | US | disclosed |
| US-20130096090-A1 | TRANSITION METAL COMPLEXES OF AMINO ACIDS AND RELATED LIGANDS AND THEIR USE AS CATALYSTS, ANTI-MICROBIALS, AND ANTI-CANCER AGENTS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130096090-A1 | TRANSITION METAL COMPLEXES OF AMINO ACIDS AND RELATED LIGANDS AND THEIR USE AS CATALYSTS, ANTI-MICROBIALS, AND ANTI-CANCER AGENTS | MCL1, GLS, ERAL1 | CTSL 327/4885CTSB 935/4885CTSK 1318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.